Cyclooxygenase-2 (COX-2) is the inducible form of cyclooxygenase and catalyzes the rate-limiting step in the formation of prostaglandins from arachidonic acid. COX-2 expression and prostaglandin production increase markedly in neurons following a variety of stimuli including inflammation and excitotoxicity. Previous studies in rodent models of ischemia have demonstrated that COX-2 activity potentiates neuronal injury. The mechanism by which COX-2 promotes neuronal injury has not been determined, but likely involves cellular changes resulting from activation of specific prostaglandin receptors, all of which are present in neurons. From preliminary studies, we hypothesize that distinct prostaglandin products may act to promote toxicity through activation of specific prostaglandin receptors and second messenger systems. In preliminary studies, we have determined that prostaglandin receptors can mediate either toxic or protective effects on neuronal survival in culture. Using in vitro culture techniques as well as in vivo studies of PG receptor knockout mice, we propose to define specific COX-2 prostaglandin metabolites and receptor mediated signaling pathways that function in promoting the toxic effects of COX-2 enzymatic activity in stroke.
In Aim 1, using receptor specific agonists and antagonists in neuronal culture, we will determine the effects of activation of individual PG receptor subtypes on neuronal survival. We will then correlate the toxic or protective effects of individual PG receptors with downstream signaling pathways focusing on cAMP production and changes in intracellular Ca2+ levels in Aim 2.
In Aim 3, we will quantify the prostaglandin response following ischemia at various time points during reperfusion and determine the level of expression and anatomic localization of PG receptors. We will test whether toxic prostaglandins and prostaglandin receptors are dominantly induced in this paradigm.
In Aim 4, we will confirm our findings in vivo, and test the function of selected PG receptors using prostaglandin receptor knockout mice that have been made available to us for study. From these studies, we hope to define specific PG receptor mediated pathways that impact on neuronal survival in stroke, and that can be targeted in future studies for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS045727-01A1
Application #
6732211
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Jacobs, Tom P
Project Start
2004-01-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
1
Fiscal Year
2004
Total Cost
$264,666
Indirect Cost
Name
Johns Hopkins University
Department
Neurology
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Taniguchi, Hidetoshi; Anacker, Christoph; Wang, Qian et al. (2014) Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy. Exp Neurol 255:30-7
Taniguchi, Hidetoshi; Anacker, Christoph; Suarez-Mier, Gabriela Beatriz et al. (2011) Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy. Neurosci Lett 504:185-90
Liang, Xibin; Lin, Lu; Woodling, Nathaniel S et al. (2011) Signaling via the prostaglandin Eýýý receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. J Clin Invest 121:4362-71
Andreasson, Katrin (2010) Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91:104-12
Savonenko, A; Munoz, P; Melnikova, T et al. (2009) Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor. Exp Neurol 217:63-73
Hyman, Joel M; Firestone, Ari J; Heine, Vivi M et al. (2009) Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 106:14132-7
Li, Jun; Liang, Xibin; Wang, Qian et al. (2008) Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Neurosci Lett 438:210-5
Wu, Liejun; Wang, Qian; Liang, Xibin et al. (2007) Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci Lett 421:253-8
Liang, X; Wu, L; Wang, Q et al. (2007) Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci 33:94-9
Liu, Dong; Wu, Liejun; Breyer, Richard et al. (2005) Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 57:758-61